In addition, TransCelerate executives and member organizations, such as Amgen, Eli Lilly, GSK, and more, will present 10 impactful sessions at the conference, addressing critical and relevant topics ...
Egnyte, a leader in secure content collaboration and governance, and Espero, a pioneer in clinical trial eProtocol innovation, today announced a strategic partnership that combines their advanced ...
Vigil Neuroscience, Inc., a clinical-stage biotechnology company listed on the Nasdaq under the symbol VIGL, recently unveiled promising results from its Phase 1 clinical trial for the experimental ...
The Company is also pleased to announce the appointment of Janet Huffman as interim Chief Executive Officer. Since joining Oragenics, Ms. Huffman has played a pivotal role in driving the Company’s ...
Advarra conducted a survey of sites, sponsors, and CROs that revealed three biggest barriers to stakeholder collaboration: communications, staffing, and technology.